News

News & Milestones

The latest announcements, events, and milestones from Evoq Technologies.

Evoq Technologies will be exhibiting at AAOptom 2026.

If you plan to attend AAOptom in Anaheim, CA this year, we invite you to visit EVOQ Technologies during September 30th to October 3rd at Booth 566 as we exhibit at the meeting for the first time.

Read More >

EVOQ Technologies Awarded U.S. Patent for Mobile, Active Retinal Function Testing

Patent covers a mobile-device-based system that delivers visual stimulation and wirelessly records ocular electrophysiological responses.

Read More >

Evoq Technologies Announces the Appointment of Kasia Hein-Peters, M.D., as the New CEO

Dr. Hein-Peters takes responsibility for expanding EVOQ Technologies' market presence and driving revenue growth through fundraising, strategic partnerships and product launches.

Read More >

Twilight™: A Breakthrough, FDA-Registered Class I Medical Device

LAS VEGAS—(EINPRESSWIRE)—Evoq Technologies (evoqtechnologies.com) today announced a major milestone for eye care, confirming that its innovative diagnostic device, Twilight™, is officially registered and listed with the U.S. Food and Drug Administration (FDA) as a Class I medical device and is now available for sale in the United States.

Read More >